Byron Emin
Analyst
Piper Sandler
Equibles does not estimate personal net worth.
About Byron Emin
Byron Emin is recorded as Analyst at Piper Sandler. Byron Emin has spoken on 1 earnings call across 1 company, most recently for Viking Therapeutics, Inc. on October 28, 2026. The companies whose calls Byron Emin spoke on are classified in the Healthcare sector.
Byron Emin on recent calls
“What's the expected weight loss that you project for the 17.5 milligram weekly dose in Vanquish 1 at week 78, Given the data from the 17.5 milligram weekly dose at week 21 and week 33 from the maintenance trial.”
Affiliation history
-
Piper Sandler
Analyst
Transcript header (unverified)
Current